69 results
Page 2 of 4
8-K
EX-99.1
l3qy52
6 Oct 22
Motus GI Granted a U.S. Patent for Prepless Colonoscopy Methods
9:15am
8-K
EX-99.1
4tbaoeyh 1c2qqh
29 Sep 22
Regulation FD Disclosure
9:15am
8-K
EX-99.1
ube0dfb
11 Aug 22
Motus GI Reports Second Quarter 2022 Financial Results
4:10pm
8-K
EX-99.1
0rod7jpfyfsqibj t47
11 Aug 22
Other Events
8:05am
8-K
EX-99.1
vsu4ucjknmkwp
24 May 22
Motus GI Announces Positive Topline Data From EU Study of the Pure-Vu System
4:10pm
8-K
EX-99.1
y1nl3tyntm5uh3
12 May 22
Motus GI Reports First Quarter 2022 Financial Results
4:10pm
8-K
EX-99.1
9ikt8vagl63w8ac3
21 Apr 22
Regulation FD Disclosure
8:05am
8-K
EX-99.1
t1irlb8yus4fi
29 Mar 22
Motus GI Reports Fourth Quarter and Full Year 2021 Financial Results
4:05pm
8-K
EX-99.1
l3i6jfk8f2 4n
24 Feb 22
Motus GI Granted 180-Day Extension to Meet NASDAQ Minimum Bid Price Requirement
8:10am
8-K
EX-99.1
ul6sw0dzdbk72r
14 Feb 22
Motus GI Receives FDA Clearance to Market the Pure-Vu® EVS System
6:40am
8-K
EX-99.1
74dlrnhzk6qw01p
16 Dec 21
Motus GI Announces U.S. Patent For The Pure-Vu® System's Automatic Self-Purging Features
8:40am
8-K
EX-99.1
hoqhsswz7m 2aoqhr6
12 Nov 21
Motus GI Reports Third Quarter 2021 Financial Results and Provides Corporate Update
8:07am
8-K
EX-99.1
88rbrr2ra614f9 rku
26 Oct 21
Motus GI Announces Presentation of Results from Independent Study of Pure-Vu System in IBP Patients at the 2021 ACG Annual Scientific Meeting
8:12am
8-K
EX-99.1
h42wb2qzjpgb5k7
8 Sep 21
Motus GI Announces Enrollment of Patients at Second Site in the European Union
8:16am